Cargando…
Bispecific antibody targeting TGF-β and PD-L1 for synergistic cancer immunotherapy
The PD-1/PD-L1 signaling pathway plays a crucial role in cancer immune evasion, and the use of anti-PD-1/PD-L1 antibodies represents a significant milestone in cancer immunotherapy. However, the low response rate observed in unselected patients and the development of therapeutic resistance remain ma...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373067/ https://www.ncbi.nlm.nih.gov/pubmed/37520520 http://dx.doi.org/10.3389/fimmu.2023.1196970 |